EBS Technologies

The company develops and provides the Eyetronic therapy, a non-invasive medical system designed to treat vision loss caused by glaucoma and optic nerve damage. The technology uses individualized alternating current stimulation to stimulate the metabolism of nerve cells, aiming to restore function and prevent further cell degradation. The therapy is targeted at patients suffering from visual field restrictions and is administered through specialized clinical centers.